Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples